Mural Oncology (MURA) EBITDA (2022 - 2025)
Mural Oncology (MURA) EBITDA from Mar 31, 2022 to Sep 30, 2025. The TTM Mural Oncology (MURA) EBITDA is -$119M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Mural Oncology (MURA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -24.29% |
| 3 Years TTM | -5.13% |
| All Time TTM | -15.07% |
Annual EBITDA change of Mural Oncology (MURA)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$84M | -37.34% |
| 2024 | -$135M | -30.42% |
| 2023 | -$194M | +5.61% |
| 2022 | -$183M | N/A |